Cargando…

Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling

The aim of this study was to use a combined structure and pharmacophore modeling approach to extract information regarding dopamine D(1) receptor agonism and D(1)/D(2) agonist selectivity. A 3D structure model of the D(1) receptor in its agonist-bound state was constructed with a full D(1) agonist p...

Descripción completa

Detalles Bibliográficos
Autores principales: Malo, Marcus, Brive, Lars, Luthman, Kristina, Svensson, Peder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382191/
https://www.ncbi.nlm.nih.gov/pubmed/22315216
http://dx.doi.org/10.1002/cmdc.201100546
_version_ 1782236464142090240
author Malo, Marcus
Brive, Lars
Luthman, Kristina
Svensson, Peder
author_facet Malo, Marcus
Brive, Lars
Luthman, Kristina
Svensson, Peder
author_sort Malo, Marcus
collection PubMed
description The aim of this study was to use a combined structure and pharmacophore modeling approach to extract information regarding dopamine D(1) receptor agonism and D(1)/D(2) agonist selectivity. A 3D structure model of the D(1) receptor in its agonist-bound state was constructed with a full D(1) agonist present in the binding site. Two different binding modes were identified using (+)-doxanthrine or SKF89626 in the modeling procedure. The 3D model was further compared with a selective D(1) agonist pharmacophore model. The pharmacophore feature arrangement was found to be in good agreement with the binding site composition of the receptor model, but the excluded volumes did not fully reflect the shape of the agonist binding pocket. A new receptor-based pharmacophore model was developed with forbidden volumes centered on atom positions of amino acids in the binding site. The new pharmacophore model showed a similar ability to discriminate as the previous model. A comparison of the 3D structures and pharmacophore models of D(1) and D(2) receptors revealed differences in shape and ligand-interacting features that determine selectivity of D(1) and D(2) receptor agonists. A hydrogen bond pharmacophoric feature (Ser-TM5) was shown to contribute most to the selectivity. Non-conserved residues in the binding pocket that strongly contribute to D(1)/D(2) receptor agonist selectivity were also identified; those were Ser/Cys(3.36), Tyr/Phe(5.38), Ser/Tyr(5.41), and Asn/His(6.55) in the transmembrane (TM) helix region, together with Ser/Ile and Leu/Asn in the second extracellular loop (EC2). This work provides useful information for the design of new selective D(1) and D(2) agonists. The combined receptor structure and pharmacophore modeling approach is considered to be general, and could therefore be applied to other ligand–protein interactions for which experimental information is limited.
format Online
Article
Text
id pubmed-3382191
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher WILEY-VCH Verlag
record_format MEDLINE/PubMed
spelling pubmed-33821912012-06-27 Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling Malo, Marcus Brive, Lars Luthman, Kristina Svensson, Peder ChemMedChem Full Papers The aim of this study was to use a combined structure and pharmacophore modeling approach to extract information regarding dopamine D(1) receptor agonism and D(1)/D(2) agonist selectivity. A 3D structure model of the D(1) receptor in its agonist-bound state was constructed with a full D(1) agonist present in the binding site. Two different binding modes were identified using (+)-doxanthrine or SKF89626 in the modeling procedure. The 3D model was further compared with a selective D(1) agonist pharmacophore model. The pharmacophore feature arrangement was found to be in good agreement with the binding site composition of the receptor model, but the excluded volumes did not fully reflect the shape of the agonist binding pocket. A new receptor-based pharmacophore model was developed with forbidden volumes centered on atom positions of amino acids in the binding site. The new pharmacophore model showed a similar ability to discriminate as the previous model. A comparison of the 3D structures and pharmacophore models of D(1) and D(2) receptors revealed differences in shape and ligand-interacting features that determine selectivity of D(1) and D(2) receptor agonists. A hydrogen bond pharmacophoric feature (Ser-TM5) was shown to contribute most to the selectivity. Non-conserved residues in the binding pocket that strongly contribute to D(1)/D(2) receptor agonist selectivity were also identified; those were Ser/Cys(3.36), Tyr/Phe(5.38), Ser/Tyr(5.41), and Asn/His(6.55) in the transmembrane (TM) helix region, together with Ser/Ile and Leu/Asn in the second extracellular loop (EC2). This work provides useful information for the design of new selective D(1) and D(2) agonists. The combined receptor structure and pharmacophore modeling approach is considered to be general, and could therefore be applied to other ligand–protein interactions for which experimental information is limited. WILEY-VCH Verlag 2012-03-05 2012-02-07 /pmc/articles/PMC3382191/ /pubmed/22315216 http://dx.doi.org/10.1002/cmdc.201100546 Text en Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Full Papers
Malo, Marcus
Brive, Lars
Luthman, Kristina
Svensson, Peder
Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
title Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
title_full Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
title_fullStr Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
title_full_unstemmed Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
title_short Investigation of D(1) Receptor–Agonist Interactions and D(1)/D(2) Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
title_sort investigation of d(1) receptor–agonist interactions and d(1)/d(2) agonist selectivity using a combination of pharmacophore and receptor homology modeling
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382191/
https://www.ncbi.nlm.nih.gov/pubmed/22315216
http://dx.doi.org/10.1002/cmdc.201100546
work_keys_str_mv AT malomarcus investigationofd1receptoragonistinteractionsandd1d2agonistselectivityusingacombinationofpharmacophoreandreceptorhomologymodeling
AT brivelars investigationofd1receptoragonistinteractionsandd1d2agonistselectivityusingacombinationofpharmacophoreandreceptorhomologymodeling
AT luthmankristina investigationofd1receptoragonistinteractionsandd1d2agonistselectivityusingacombinationofpharmacophoreandreceptorhomologymodeling
AT svenssonpeder investigationofd1receptoragonistinteractionsandd1d2agonistselectivityusingacombinationofpharmacophoreandreceptorhomologymodeling